Complementary DNA cloning, functional expression and characterization of a novel cytochrome P450, CYP2D50, from equine liver

Biochemical Pharmacology

Volumn 76, Issue 7, 2008, Pages 904-911

  Knych, H K DiMaio ^a   Stanley, S D ^a  

^a School of Veterinary Medicine   (United States)

Author keywords

CYP2D; CYP450; Debrisoquine; Dextromethorphan; Horse; Phase I metabolism

Indexed keywords

4 HYDROXYDEBRISOQUINE; COMPLEMENTARY DNA; CYTOCHROME P450 2D; CYTOCHROME P450 2D50; CYTOCHROME P450 2D6; CYTOCHROME P450 ISOENZYME; DEXTROMETHORPHAN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME MECHANISM; FEMALE; HORSE; LIVER; LIVER METABOLISM; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; ANIMALS; CLONING, MOLECULAR; CYTOCHROME P-450 ENZYME SYSTEM; DEBRISOQUIN; DEXTROMETHORPHAN; DNA, COMPLEMENTARY; FEMALE; HORSES; HUMANS; LIVER; MALE; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT;

EID: 51249096541     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.07.016     Document Type: Article

References (13)

1. Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J 5 (2005) 6-13
2. Chauret N., Gauthier A., Martin J., and Nicoll-Griffith D.A. In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse. Drug Metab Dispos 10 (1997) 1130-1136
3. Lakrtiz J., Winder B.S., Noorouz-Zadeh J., Huang T.L., Buckpitt A.R., Hammock B.D., et al. Hepatic and pulmonary enzyme activities in horses. Am J Vet Res 61 2 (2000) 152-157
4. Nebbia C., Dacasto M., Rossetto Giaccherino A., Giuliano Albo A., and Carletti M. Comparative expression of liver cytochrome P450-dependent monooxygenases in the horse and in other agricultural and laboratory species. Vet J 165 (2003) 53-64
5. Omura T., and Sato R. The carbon monoxide-binding pigment of liver microsomes. J Biol Chem 239 (1964) 2370-2378
6. Yasukochi Y., and Masters B.S. Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography. J Biol Chem 251 (1976) 5337-5344
7. Kumar V., Rock D.A., Warren C.J., Tracy T.S., and Wahlstrom J.L. Enzyme source effects on CYP2C9 kinetics and inhibition. Drug Metab Dispos 34 (2006) 1903-1908
8. Mankowski D.C., Laddison K.J., Christopherson P.A., Ekins S., Tweedie D.J., and Lawton M.P. Molecular cloning, expression and characterization of CYP2D17 from cynomolgus monkey liver. Arch Biochem Biophys 372 (1999) 189-196
9. Shou M., Norcros R., Sandig G., Lu P., Yinghe L., Lin Y., et al. Substrate specificity and kinetic properties of seven heterologously expressed dog cytochromes P450. Drug Metab Dispos 31 (2003) 1161-1169
10. Hichiya H., Kuramoto S., Yamamoto S., Shinoda S., Hanioka N., Narmatsu S., et al. Cloning and functional expression of a novel marmoset cytochrome P450 2D enzyme, CYP2D30: comparison with the known marmoset CYP2D19. Biochem Pharmacol 68 (2004) 164-175
11. Roussel F., Duignan D.B., Lawton M.P., Obach R.S., Strick C.A., and Tweedie D.J. Expression and characterization of canine cytochrome P450 2D15. Arch Biochem Biophys 357 (1998) 27-36
12. Hosseinpour F., and Wikvall K. Porcine microsomal vitamin D(3) hydroxylase (CYP2D25). Catalytic properties, tissue distribution, and comparison with human CYP2D6. J Biol Chem 275 (2000) 34650-34655
13. 2-insensitive NADH-benzamidoxime reductase. J Biol Chem 272 (1997) 19615-19620